New study aims to predict which fibroids respond best to Non-Invasive ultrasound treatment

NCT ID NCT02386137

Completed Knowledge-focused Sponsor: University Hospital, Bordeaux Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at 40 women with symptomatic uterine fibroids to understand why MR-guided focused ultrasound (HIFU) works better for some than others. Researchers used MRI and contrast-enhanced ultrasound to measure fibroid blood flow, stiffness, and other features before treatment. The goal was to see which factors predict a larger volume of fibroid tissue being destroyed, which could help doctors choose the best candidates for this non-invasive procedure.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: MR-guided high-intensity focused ultrasound (HIFU) ablation
What this could lead to: If successful, this could help doctors predict which fibroids will respond best to HIFU, improving treatment planning and outcomes.
What could go wrong: This is a small, completed observational study (40 participants) that does not test a new treatment. It only explores factors that may influence ablation efficiency, so it won't directly change care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for UTERINE FIBROID are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

leiomyoma uterine corpus leiomyoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

UTERINE FIBROID

Contacts and locations

Locations

Service d'imagerie médicale

Bordeaux, 33000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.